Zhejiang Tianyu Pharmaceutical Co Ltd Class A 300702
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 20.85
- Day Range
- CNY 20.67–21.00
- 52-Week Range
- CNY 13.16–28.00
- Bid/Ask
- CNY 20.75 / CNY 20.76
- Market Cap
- CNY 7.22 Bil
- Volume/Avg
- 826,820 / 3.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 226.96
- Price/Sales
- 2.93
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Zhejiang Tianyu Pharmaceutical Co Ltd is the pharmaceutical manufacturing company. Its main business is the development, production and sales of active pharmaceutical ingredients and intermediates. The products mainly include antihypertensive drug and intermediates, anti-asthma drug raw materials and intermediates, antiviral drug intermediates. Its products are well sold in domestic and overseas markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 4,690
- Website
- http://www.tianyupharm.com
Comparables
Valuation
|
Metric
|
300702
|
000739
|
600521
|
|---|---|---|---|
Price/Earnings (Normalized) | 226.96 | 17.86 | 24.41 |
Price/Book Value | 2.07 | 2.88 | 3.10 |
Price/Sales | 2.93 | 1.59 | 2.89 |
Price/Cash Flow | 60.48 | 16.96 | 9.37 |
Price/Earnings
300702
000739
600521
Financial Strength
|
Metric
|
300702
|
000739
|
600521
|
|---|---|---|---|
Quick Ratio | 0.37 | — | 0.81 |
Current Ratio | 1.16 | — | 1.33 |
Interest Coverage | −0.80 | — | 6.22 |
Quick Ratio
300702
000739
600521
Profitability
|
Metric
|
300702
|
000739
|
600521
|
|---|---|---|---|
Return on Assets (Normalized) | 0.38% | 8.04% | 5.62% |
Return on Equity (Normalized) | 0.68% | 17.08% | 13.24% |
Return on Invested Capital (Normalized) | 1.26% | 13.90% | 7.70% |
Return on Assets
300702
000739
600521
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Cbgytcfdy | Wjn | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Fmvbhnfqx | Qfmfl | $74.3 Bil | |
HLN
| Haleon PLC ADR | Xlttffgn | Qdcwh | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Fygsbqhh | Jnpm | $19.1 Bil | |
VTRS
| Viatris Inc | Ycswmfw | Yczm | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Znfvrmys | Hwvj | $11.7 Bil | |
CTLT
| Catalent Inc | Zpvhhzhm | Ccqqw | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Jrvnmfmv | Kdzc | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Mwmndzqzn | Rhsh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xncstgp | Khpdyf | $3.3 Bil |